Logo image of ALSPW.PA

SPINEWAY (ALSPW.PA) Stock Fundamental Analysis

EPA:ALSPW - Euronext Paris - Matif - FR001400N2P2 - Common Stock - Currency: EUR

0.115  +0.02 (+23.79%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ALSPW. ALSPW was compared to 55 industry peers in the Health Care Equipment & Supplies industry. ALSPW has a bad profitability rating. Also its financial health evaluation is rather negative. ALSPW is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALSPW had negative earnings in the past year.
ALSPW had a negative operating cash flow in the past year.
In the past 5 years ALSPW always reported negative net income.
In the past 5 years ALSPW always reported negative operating cash flow.
ALSPW.PA Yearly Net Income VS EBIT VS OCF VS FCFALSPW.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M

1.2 Ratios

With a Return On Assets value of -27.99%, ALSPW is not doing good in the industry: 76.36% of the companies in the same industry are doing better.
ALSPW has a worse Return On Equity (-37.63%) than 65.45% of its industry peers.
Industry RankSector Rank
ROA -27.99%
ROE -37.63%
ROIC N/A
ROA(3y)-14.09%
ROA(5y)-32.01%
ROE(3y)-18.67%
ROE(5y)-48.1%
ROIC(3y)N/A
ROIC(5y)N/A
ALSPW.PA Yearly ROA, ROE, ROICALSPW.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -100 -200 -300 -400

1.3 Margins

ALSPW's Gross Margin of 69.23% is fine compared to the rest of the industry. ALSPW outperforms 76.36% of its industry peers.
In the last couple of years the Gross Margin of ALSPW has grown nicely.
ALSPW does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y49.59%
GM growth 5Y26.91%
ALSPW.PA Yearly Profit, Operating, Gross MarginsALSPW.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

More info and screens

3

2. Health

2.1 Basic Checks

ALSPW does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALSPW has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALSPW has more shares outstanding
Compared to 1 year ago, ALSPW has a worse debt to assets ratio.
ALSPW.PA Yearly Shares OutstandingALSPW.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M
ALSPW.PA Yearly Total Debt VS Total AssetsALSPW.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

2.2 Solvency

ALSPW has an Altman-Z score of 0.10. This is a bad value and indicates that ALSPW is not financially healthy and even has some risk of bankruptcy.
ALSPW's Altman-Z score of 0.10 is on the low side compared to the rest of the industry. ALSPW is outperformed by 69.09% of its industry peers.
ALSPW has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.08, ALSPW belongs to the best of the industry, outperforming 87.27% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 0.1
ROIC/WACCN/A
WACC4.21%
ALSPW.PA Yearly LT Debt VS Equity VS FCFALSPW.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M

2.3 Liquidity

ALSPW has a Current Ratio of 2.22. This indicates that ALSPW is financially healthy and has no problem in meeting its short term obligations.
ALSPW has a Current ratio of 2.22. This is in the better half of the industry: ALSPW outperforms 69.09% of its industry peers.
ALSPW has a Quick Ratio of 1.24. This is a normal value and indicates that ALSPW is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.24, ALSPW is in the better half of the industry, outperforming 69.09% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.22
Quick Ratio 1.24
ALSPW.PA Yearly Current Assets VS Current LiabilitesALSPW.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 99.00% over the past year.
ALSPW shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.19%.
ALSPW shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.06% yearly.
EPS 1Y (TTM)99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.95%
Revenue 1Y (TTM)19.19%
Revenue growth 3Y46.01%
Revenue growth 5Y10.06%
Sales Q2Q%20.31%

3.2 Future

Based on estimates for the next years, ALSPW will show a very strong growth in Earnings Per Share. The EPS will grow by 25.99% on average per year.
ALSPW is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.17% yearly.
EPS Next Y104.49%
EPS Next 2YN/A
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue Next Year-15.91%
Revenue Next 2YN/A
Revenue Next 3Y18.17%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALSPW.PA Yearly Revenue VS EstimatesALSPW.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2026 5M 10M 15M
ALSPW.PA Yearly EPS VS EstimatesALSPW.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2026 0 -5M -10M -15M -20M

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALSPW. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 0.00, the valuation of ALSPW can be described as very cheap.
Based on the Price/Forward Earnings ratio, ALSPW is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, ALSPW is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 0
ALSPW.PA Price Earnings VS Forward Price EarningsALSPW.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALSPW.PA Per share dataALSPW.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALSPW's earnings are expected to grow with 25.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3Y25.99%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALSPW!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SPINEWAY

EPA:ALSPW (3/7/2025, 7:00:00 PM)

0.115

+0.02 (+23.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)03-24 2025-03-24/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap95.45K
Analysts86.67
Price Target1.33 (1056.52%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B 0
P/tB 0.01
EV/EBITDA N/A
EPS(TTM)-33.46
EYN/A
EPS(NY)65.92
Fwd EY57321.74%
FCF(TTM)-7.24
FCFYN/A
OCF(TTM)-8.11
OCFYN/A
SpS14
BVpS25.61
TBVpS14.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.99%
ROE -37.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 69.23%
FCFM N/A
ROA(3y)-14.09%
ROA(5y)-32.01%
ROE(3y)-18.67%
ROE(5y)-48.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y49.59%
GM growth 5Y26.91%
F-Score4
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.22
Quick Ratio 1.24
Altman-Z 0.1
F-Score4
WACC4.21%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.95%
EPS Next Y104.49%
EPS Next 2YN/A
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue 1Y (TTM)19.19%
Revenue growth 3Y46.01%
Revenue growth 5Y10.06%
Sales Q2Q%20.31%
Revenue Next Year-15.91%
Revenue Next 2YN/A
Revenue Next 3Y18.17%
Revenue Next 5YN/A
EBIT growth 1Y13.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year157.59%
EBIT Next 3Y27.22%
EBIT Next 5YN/A
FCF growth 1Y-49.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-173.02%
OCF growth 3YN/A
OCF growth 5YN/A